Clearance Summary
LOBO Vascular Occlusion System (models LOBO-7 and LOBO-9) received FDA 510(k) clearance under submission number K220383, sponsored by Okami Medical. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2022-04-29.
- Submission: K220383
- Applicant / Sponsor: Okami Medical
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.3300
- Decision date: 2022-04-29
Classification & Regulation
This clearance is catalogued under FDA product code KRD and 21 CFR 870.3300, within the Cardiovascular review panel as a Class II device.